Home | Site Map | Contact Us |  Tell a Colleague | Print Page  
Roche Transplantation Roche
About Roche Transplantation Research Resources for Professionals Prescribing Information Community Support Industry Events/News
Sign Up
Login Here
E-mail
Password
Forgot Password

Important Safety and Prescribing Information

CellCept Zenapax Valcyte Learn More about Cellcept
Prescribing Information
Provided in this section is detailed information about Roche leading transplantation therapies. Read about benefits, indications, efficacy, tolerability, dosing, and more.
CellCept® (mycophenolate mofetil) 
CellCept, for maintenance immunosuppressant therapy, is the number 1 prescribed branded immunosuppressive in the U.S.13
Valcyte® (valganciclovir HCI tablets) 
Valcyte® (Valganciclovir HCI Tablets) is the most widely prescribed anti-CMV agent in the United States.
ZENAPAX® (daclizumab)
ZENAPAX prevents the acute rejection of the newly transplanted organ.
References:
13Data on file (Ref. 140-005) [2004 DDD data], Hoffmann-La Roche, Nutley, NJ 07110.

 

 

 
Privacy Statement  |  Legal Statement  |  Intended for U.S. Physician Audiences Only Copyright © 2006-2009 - Roche Laboratories Inc. All rights reserved.